Genetic Interaction Maps via Double-RNAi Screening
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current RNAi screening technologies face challenges such as high off-target effects, the need for time-consuming validation of hit genes, and the inability to systematically assess interactions between identified genes, which complicates the identification of genuine genetic hits and understanding of cellular pathways.
Innovation Solution
The development of methods using double-RNAi constructs to knock down all pairwise combinations of hit genetic elements, allowing for the calculation of genetic interactions and the creation of genetic interaction maps to predict functional associations and identify drug targets.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If traditional RNAi screening is used to identify hit genes, then genetic elements can be identified, but off-target effects complicate the identification of genuine hits
Solution Approach 1:
The patent introduces an intermediary validation step using secondary screens and genetic interaction analysis. Instead of directly accepting primary screen hits, the method uses intermediate validation through multiple independent shRNAs and interaction patterns to filter out off-target effects, thereby improving identification accuracy while accounting for harmful off-target effects.
Solution Approach 2:
The patent implements feedback mechanisms by using genetic interaction patterns to validate hit genes. The system feeds back interaction data from secondary screens to confirm genuine hits, where genuine genetic interactions should show consistent patterns across multiple shRNAs targeting the same gene, while off-target effects will not show such consistent feedback patterns.
2Quantity of substance
If RNAi screens identify large numbers of hit genes, then comprehensive coverage is achieved, but time-consuming secondary screens are required for validation
Solution Approach 1:
The patent applies partial action by not requiring validation of all identified hit genes through time-consuming secondary screens. Instead, it uses genetic interaction analysis to prioritize and validate only the most promising hits based on their interaction patterns, thereby reducing validation time while maintaining comprehensive coverage through the initial screen.
Solution Approach 2:
The patent makes the primary screen data serve multiple functions: it identifies hit genes and simultaneously provides interaction information that can be used for prioritization. The same screening data is reused for both hit identification and interaction analysis, reducing the need for separate validation steps and minimizing time loss.
3Measurement precision
If traditional methods are used to assess gene interactions, then individual gene validation is performed, but systematic assessment of how hit genes interact to form cellular pathways is not achieved
Solution Approach 1:
The patent merges individual gene validation with pathway interaction analysis into a unified approach. By combining secondary screen data with genetic interaction calculations, the method simultaneously validates individual genes and reconstructs cellular pathways, preventing loss of interaction information while maintaining validation accuracy.
Solution Approach 2:
The patent adds a new dimension of analysis by moving from single-gene validation to multi-gene interaction networks. Instead of only assessing individual gene function, the method incorporates interaction patterns as an additional dimension of information, enabling systematic pathway reconstruction without sacrificing individual gene validation accuracy.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables confident identification of hit genes, reduces off-target effects, and systematically maps genetic interactions, facilitating the discovery of novel biological pathways and optimization of drug therapies by clustering genes based on interaction patterns.
Implementation Method 1
RNA interference (RNAi), a natural cellular process by which short double-stranded RNA sequences target expressed genes for degradation and silencing
Data Source
AI summary
The present invention provides methods for conducting screens using nucleic acid elements (e.g., interfering RNAs) to confidently identify hit genetic elements. The present invention further comprises constructing vectors that contain two or more nucleic acid elements to knock down all pairwise combinations of the hit genetic elements identified from the screen. Following quantitation of the single and double-knockdown phenotypes, genetic interactions between all gene pairs can be calculated. Genes can then be clustered according to the similarity of the pattern of their interactions with all of the other genes to obtain a genetic interaction map, which can advantageously be used to predict functional associations between genes and identify drug targets for therapy such as combination cancer therapy.